A B S T R A C T The effect of thyrotropin (TSH) on the ADP-ribosylation of endogenous thyroid cell acceptor proteins was examined. Cells were "permeabilized" at 4°C in hypotonic medium and then exposed to [32p] or [3H-adenine]NAD+. The net incorporation of labeled ADP-ribose was measured by trichloroacetic acid precipitation. TSH (100 mU/ml) enhanced ADPribosylation with a maximum effect after 30-60 min in the majority of experiments. TSH stimulation was observed even when the incubation contained 1,000-fold more exogenous NAD+ than the amount of NAD+ contributed by the permeabilized cells, indicating an effect on enzymatic activity rather than an alteration in NAD+ pool size or specific activity. No incorporation of radioactivity from labeled NAD+ was observed in cells not rendered permeable to NAD+ by hypotonic shock. TSH did not increase the rate of disappearance of trichloroacetic-precipitable radioactivity and did not contain intrinsic NAD+ glycohydrolase activity. Alkali and snake venom phosphodiesterase, but not ribonuclease or deoxyribonuclease digestion of trichloroacetic acid precipitable thyroid cell radioactivity, revealed primarily 5'-AMP, consistent with an effect of TSH on mono-ADP ribosylation. Nicotinamide and thymidine (50 mM) inhibited both basal and TSHstimulated ADP-ribosylation of thyroid cell protein. Dibutyryl cyclic (c)AMP (0.1 mM) inhibited endogenous ADP-ribosylation by -35% but had no effect at lower concentrations. 0.5 mM isobutylmethylxanthine inhibited this reaction by -60%.
INTRODUCTION Previous studies from this laboratory have provided evidence that the desensitization of cultured thyroid cells to thyrotropin (TSH)1 stimulation of cyclic (c)AMP
generation is NAD+ dependent, and possibly related to mono-or poly-ADP-ribosylation of unknown thyroid cell acceptor proteins. Thus nicotinamide prevented desensitization to TSH (1) . In addition, thymidine, bromodeoxyuridine, bromouridine, and methyl analogues of nicotinamide, all of which are inhibitors of poly(ADP-ribose)polymerase activity (2) (3) (4) , and some of which inhibit mono-ADP-ribosylation (5), similarly blocked TSH desensitization (6) . After removal of TSH from cultured thyroid cells, recovery from TSH desensitization was extremely slow (incomplete after 72 h) and hastened by nicotinamide, indicating further that the desensitization process involved the covalent modification of cellular molecules rather than changes in rapidly turning-over substances such as various ions and nucleotides (6) .
While the poly-ADP-ribosylation reaction is known to play a role in DNA replication and repair (7) (8) (9) , it has been speculated that poly-, and perhaps mono-ADP-ribosylation may be important in regulating a much wider variety of cellular functions. Evidence to support this concept has been elusive. Eucaryotic poly(ADP-ribose)polymerase (7) and mono(ADP-ribose) transferase (5) have been highly purified and shown to ADP-ribosylate numerous acceptor proteins. How-ever, the physiological significance of these reactions remains poorly understood. This contrasts with the well-known pathological role of ADP-ribosylation reactions in the mediation of bacterial toxin actions on eucaryotic cells (10, 11) . In our study we have demonstrated that TSH stimulates ADP-ribosylation of endogeinous substrate in intact permeabilized thyroid cells. The data support the previously obtained evidence of a role for the ADP-ribosylation process in TSH desensitization.
METHODS
Thyroidl cell preparationi. Dog thyroids (1.5-3 g ) were obtainiedl fresh from animi'als sacrificed for other reasons. Dispersedl thyroid follicles were obtained as described (12) , except that slices were chopped at 300 ,um, collagenase digestion was in Ca+' anid Mg++-free saline, and liberated follicles were separated from tissue chunks by sedimentatioIn at 1 g. Dispersed follicles were rinsed free of collagenase with Puck's saline A (two washes at 100 g for 5 min), and then stored on ice until use a few minutes later. Thyroid cell number could not be counlted because of their association in follicles, but cellular protein was determined by the method of Lowry et al. (13) , using bovine serum albumin as standard.
ADP-ribosylatiotI assay. The hypotonic shock method of Skidmore et al. (14) for intact cells, based on previous methods (3, 15) , was used with minor modificationis. Thyroid cells from 1.5-3 g of tissue were centrifuged for 5 min at 100g, suspended in 1.3 ml hypotonic buffer (9 mM Hepes, pH 7.8, 5 mM dithiothreitol, 1 mM EGTA, 4.5 mM MgCl2 4.5% dextran), and maintained at 4°C for 30 min. This hypotonic shock procedure makes the cells permeable to subsequently added substances, such as NAD+, which normally enter intact cells with difficulty. The cells were then diluted 1:10 in a second buffer, pH 7.8, containing 40 mM Hepes, 2.5 mM dithiothreitol, 130 mM KCl, 2 mM EGTA, 2.3 mM MgCl2, 222 mM sucrose, 4% dextran, [32P]NAD+ or [3H]-NAD+ (1-2 x 106 cpm/0.2 ml), and NAD+ to achieve the final concentrations indicated for each experiment. In initial experiments the buffer also included 1 mM ATP, 6.6 mg/ml creatine phosphokinase, and 20 mM creatine phosphate. This ATP-regenerating system was omitted in later experiments l)ecause it did not influence the results obtained. Care was taken to ensure that the buffering capacity of this solution was sufficient for the various agents included, such as dibutyryl (Bt2) cAMP. The reaction (0.2 ml final volume) was begun by warming to 25°C. After the indicated periods of time the reaction was stopped with 3 ml of 10% trichloroacetic acid. The precipitates were collected on 24 mm Diam GFC filters using an Amicon Vacuum Filtration Manifold. The filters were washed once with absolute ethanol and six times with 10% trichloroacetic acid. After drying, the filters were treated with 0.4 ml of NCS (Amersham, Arlington Heights, Ill.) for 30 min, 8 ml of Scintiverse (Fisher Scientific Co., Pittsburgh, Pa.) was added and the samples were then counted on a liquid scintillation counter.
Identification of the digestion products of trichloroacetic acid-insoluble mnaterial derived from labeled NAD+. Cells permeabilized as described above were incubated in (Table II) . Release of acidinsoluble material was small (18% after 3 h) and was no greater than in the absence of ribonuclease. In contrast, phosphodiesterase or NaOH treatment each independently yielded -95% acid-insoluble radioactivity after 3 h. The foregoing data therefore strongly suggested that TSH stimulated predominantly mono-ADP-ribosylation of endogenous thyroid substrate.
Effect of nicotinamide and thymidine on TSHstimulated ADP-ribosylation. Nicotinamide and thymidine are potent inhibitors of poly(ADP-ribose)polymerase and NAD+ glycohydrolase activity. As mentioned previously, these agents (at 50 mM) also prevent TSH desensitization in cultured thyroid cells (6) . Simi- (Fig. 3) . Lack of effect of TSH on ADP-ribose degradation. TSH could increase net ADP-ribosylation of endogenous thyroid substrate either by increasing production or by inhibiting degradation of ADP-ribose. Permeabilized thyroid cells were therefore incubated in [32P]NAD+ for 45 min at which point 75 mM nicotinamide together with 100 mU/ml TSH was added, the former to inhibit further ADP-ribose synthesis (2, 5) . Control cells were treated with nicotinamide without TSH. Degradation of trichloroacetic acid-insoluble material was rapid (tY2 of -6 min) (Fig. 4) . TSH was without effect on this rate of disappearance.
Effect ofBt2cAMP on ADP-ribosylation. Desensitization of the cAMP response to TSH stimulation is one of the few effects of TSH not mediated by cAMP as a second messenger (20) . Indeed, preexposure of thyroid cells to 0.1 mM Bt2cAMP enhanced the subsequent cAMP response to TSH (20) . It was therefore important to test whether Bt2cAMP altered ADPribosylation of endogenous thyroid substrate. Not only did 0.1 mM Bt2cAMP not mimic the effect of TSH, but significant inhibition of enzyme activity was observed (Fig. 5) . At 0.5 mM, 3-isobutyl-1-methylxanthine has little effect on ADP-ribosylation (albeit of the poly variety) in 3T3 cells (13% inhibition at 1 mM) (4), but is a potent inhibitor of thyroid cell cAMP catabolism (12) . This agent inhibited thyroid cell ADP-ribosylation by 60% (Fig. 5) , providing further support that cAMP inhibits, rather than stimu- FIGURE 4 Lack of effect of TSH in altering the degradation rate of NAD+-derived, trichloroacetic acid-insoluble radiolabeled material. Cells made permeable to [32P]NAD' were incubated for 45 min at 25°C, as described in Methods. After adding nicotinamide (75 mM final concentration) to block the reaction, aliquots were incubated in the absence (0) or in the presence ofTSH (100 mU/ml) (0). At the indicated times 0.2 ml portions were taken and trichloroacetic acidprecipitable radioactivity was measured as previously described. Each point represents the mean+SE of triplicate determinations. The insert indicates a semilogarithmic plot of the data. (21) have indicated that progesterone and estrogen alter poly-(ADP-ribose) polymerase activity in the quail oviduct. Similar effects of other polypeptide hormones on their respective target tissues are clearly possible and amenable to investigation. The effect of TSH on ADPribosylation is not mediated by cAMP, raising the possibility of an alternative second messenger. TSH enhances ADP-ribose formation rather than decreases ADP-ribose degradation. Of interest is that the product t1/2 of 6 min is similar to that reported by Gill (22) for (22) for poly(ADP-ribose).
The reason for the variability in the time of maximum TSH stimulation of ADP-ribosylation is not presently clear. It does not appear to be dependent on NAD+ substrate concentration (Fig. 1) . Possible explanations include variable activity in different thyroids of the deribosylation mechanism that is proceeding unchecked simultaneously with increased ADP-ribosylation activity. The duration of cell permeability to NAD+ after reconstitution of the cells in isotonic medium may also vary from one experiment to another.
The kinetics of the TSH-induced stimulation of net ADP-ribosylation are difficult to understand. Thus the TSH effect is seen primarily when the rate of accumulation of radiolabeled ADP-ribosylated material in the control cells is very low. Contributing to these complicated kinetics are, (a) (there is a high rate of degradation of ADP-ribosylated material simultaneous with its synthesis), (b) the reaction is conducted in isotonic medium after intracellular introduction of NAD+ under hypotonic conditions, and is therefore not at equilibrium, and (c) there may be a lag-phase in the initiation of TSH action. Further studies will be necessary to elucidate these complex kinetics.
The question arises as to whether TSH stimulates the net formation of poly(ADP-ribose), mono-ADPribose, or both. Although the hypotonic shock method to introduce NAD+ into cells, as used in this study, has been used extensively to measure poly(ADPribose)polymerase activity (3, 14, 15) , we observed that the major alkali and phosphodiesterase digestion product of cellular trichloroacetic acid-insoluble radioactivity (and the product whose concentration was increased by TSH) was 5'-AMP. Having determined that no residual labeled NAD+ remained after extensive washing, the source of this 5'-AMP is likely to be mono(ADP-ribose). However we cannot exclude the possibility that mono(ADP-ribose) was a product of poly(ADP-ribose) broken into subunits during the analytical procedure. Phosphoribosyl-AMP was inconsistently observed in small amounts (<10%), and its concentration was not affected by TSH stimulation. Consistent with our data, Maayan (23) demonstrated nearly 20 yr ago that nicotinamide in concentrations similar to those we used, inhibited NAD+ glycohydrolase activity in thyroid homogenates. The most likely explanation for our data is that TSH stimulates thyroid NAD+ glycohydrolase and ADP-ribosyl transferase activity in the thyroid by a cAMP-independent mechanism.
In coming to this conclusion it is important to consider an effect of TSH on the specific activity of cellular NAD+, or substrate availability, rather than on enzyme activity. Fortunately, as shown in previous studies (3) , these complexities are avoided by the use of the permeabilized cell system that eliminates separate intra-and extracellular pools. The permeabilized cells contribute very little NAD+ to the reaction mixture, and, as confirmed herein, formation of precipitable ADP-ribose is dependent upon the amount of NAD+ added to the incubation mixture and not on endogenous cellular NAD+ content. Thus, addition of NAD+ to the incubation at a concentration of 1 mM is -1,000-fold greater than the estimated NAD+ contribution by the cells to the medium (3). TSH also does not enhance transport of labeled NAD+ into cells not subjected to hypotonic shock, as evidenced by a complete lack of incorporation of radioactivity into cellular material in the presence of TSH (Fig. 1) .
Another important consideration in interpreting our data was that TSH-induced ADP-ribosylation was due
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S. Filetti and B. Rapoport to intrinsic TSH NAD+ glycohydrolase activity, for which there is preliminary evidence (16) . However, despite much effort we have not been able to observe such activity in our cell-free system. In addition, as previously mentioned, in the presence of cells not made permeable, TSH does not increase incorporation or radioactivity from labeled NAD+ (Fig. 1) . The reasons for this difference are unclear, but may relate to different TSH preparations used, different incubation conditions, and a different system of analysis. These data are consistent with previously obtained evidence using inhibitors of ADP-ribosylation reactions that the ADP-ribosylation process plays a role in TSH desensitization in thyroid cells. The timecourse of TSH enhancement of ADP-ribosylation is also similar to the onset of TSH desensitization (12) . Both phenomena also appear to be cAMP independent. It should also be noted that ADP-ribosylation (albeit poly-) is of importance in the modulation of nuclear and translational activities, whereas TSH desensitization is dependent on new protein synthesis (20) . The scenario is now unfolding of hormonal modulation of cellular function by a variety of cAMP-independent mechanisms, now including ADP-ribosylation.
